Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

A young woman developed a vision-threatening eye condition after using minoxidil for hair loss, which improved when she stopped the medication.

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.

PRX102 is essential for rice root hair growth by helping transport substances to the tips.

Scalp cooling is cost-effective for reducing hair loss from chemotherapy and should be covered by insurance.

A committee was formed to improve hair restoration for certain hair diseases by collecting and analyzing data.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

A Chinese boy's scalp infection from a guinea pig was cured with medication.

PRP gel is a safe, affordable treatment needing trained staff and proper facilities.

Cyperus rotundus oil effectively reduces unwanted hair without side effects.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Polish medical societies recommend personalized treatment for PCOS based on the patient's specific symptoms and use the Rotterdam criteria for diagnosis.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.